Acral persistent papular mucinosis: A rare variant of cutaneous mucinosis
DOI:
https://doi.org/10.66344/jpad.14.4.2004.832Keywords:
Papular mucinosis, acral persistent papular mucinosis, scleromyxedema, lichen myxedematosusAbstract
Acral persistent papular mucinosis (APPM) is a distinctive form of dermal mucinosis notassociated with systemic diseases. We report such a case in a sixty years old male whopresented with few small papular lesionsReferences
Jeremy E R. Papular mucinosis.
Dermatology Online J 2001; 7: 13.
Stephens CJM, McKee PH, Black
MM. The dermal mucinoses. Adv
Dermatol 1993; 21:293.
Clark BJ, Mowat A, Fallowfield ME,
Lee FD. Papular mucinosis. - is the
inflammatory cell infiltrate neoplastic
- the presence of a monotypic plasma
cell population demonstrated by insitu
hybridization. Br J Dermatol
; 135: 467-70.
Menni S, Cavicchini S, Brezzi A et
al. Acral persistent papular mucinosis
in two sisters. Clin Exp Dermatol
; 20: 431-3
Howden SM, Herndon JH Jr,
Freeman RG. Lichen
myxedematosus: a dermal infiltrate
disorder responsive to
cyclophosphamide therapy. Arch
Dermatol 1975; 111: 1325-30.
Bata-Csorgo Z, Husz S, Foldes M et
al. Scleromyxedema. J Am Acad
Dermatol 1999; 41: 343-6.
Caputo R, Grimalt R, Gelmetti C.
Self-healing juvenile cutaneous
mucinosis. Arch Dermatol 1995; 131:
-61.
Tschen JA, Chang JR.
Scleromyxedema: treatment with
interferon alpha. J Am Acad Dermatol
; 40: 303-6.
Liiter RK. Scleromyxedema: response
to high-dose intravenous
immunoglobulin (hdIVIg). J Am Acad
Dermatol 2000; 43: 403-6.
Borradori L, Aractingi S, Blanc F et
al. Acral persistent papular mucinosis
and IgA monoclonal gammopathy:
report of a case. Dermatology 1992;
: 134-6.
Downloads
Published
How to Cite
Issue
Section
License
Submission declaration
Authors retain the copyright to their work and grant the 'Journal of Pakistan Association of Dermatologists (JPAD)' the right of first publication under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. This license allows others to share, adapt, and reuse the work for any purpose, including commercial use, as long as appropriate credit is given to the original authors and the journal.
By submitting a manuscript, authors confirm that the work has not been published previously (except as an abstract, lecture, or academic thesis), is not under review elsewhere, and has been approved by all authors and relevant authorities. Once accepted, the article will be openly accessible under the CC BY 4.0 license, ensuring wide dissemination and reuse with proper attribution.
